Iterative Scopes, Inc.

Iterative Scopes, Inc. specializes in endoscopic video image interpretive units, primarily focused on the SKOUT system. These devices combine hardware and software to capture, process, and interpret real-time video imagery during endoscopic procedures, aiding clinicians in visualization and diagnostic support. The company’s solutions are designed for procedural settings where enhanced imaging clarity is critical.

Iterative Scopes, Inc. is headquartered in the United States. As a U.S.-based manufacturer, its devices are subject to FDA oversight. The company’s products fall under FDA Class II classification, which typically requires premarket notification (510(k)) clearance before commercial distribution in the U.S. This classification reflects moderate risk, necessitating regulatory review to ensure safety and effectiveness.

Devices from Iterative Scopes, Inc. are included in the FDA’s 510(k) database, which tracks premarket submissions for Class II devices, and the FDA’s Unique Device Identifier (UDI) system. These registries ensure traceability and transparency in the medical device supply chain, allowing healthcare providers, regulators, and other stakeholders to verify device details and compliance status.

The devices produced by Iterative Scopes, Inc., such as the SKOUT system, are classified as FDA Class II. This classification is determined by the FDA based on factors like the device’s intended use, potential risks, and benefits. Class II devices generally require a 510(k) clearance to demonstrate substantial equivalence to a legally marketed predicate device, ensuring they meet safety and performance standards before entering the market.